Gene Symbol |
Definition |
Felxi PID |
Halo PID |
Nluc-N PID |
Nluc-C PID |
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
PTPRN2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
FXC00525
|
FHC00525
|
FNC00525N
|
FNC00525C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
ZNF395 |
zinc finger protein 395 |
FXC03445
|
FHC03445
|
FNC03445N
|
FNC03445C
|
HSPD1 |
heat shock 60kDa protein 1 (chaperonin), transcript variant 1 |
FXC03568
|
FHC03568
|
FNC03568N
|
FNC03568C
|
GAD2 |
glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa), transcript variant 1 |
FXC03881
|
FHC03881
|
FNC03881N
|
FNC03881C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
INS |
insulin, transcript variant 1 |
FXC08231
|
FHC08231
|
FNC08231N
|
FNC08231C
|
ICA1 |
islet cell autoantigen 1, 69kDa, transcript variant 4 |
FXC08384
|
FHC08384
|
FNC08384N
|
FNC08384C
|
HLA-DMA |
major histocompatibility complex, class II, DM alpha |
FXC08554
|
FHC08554
|
FNC08554N
|
FNC08554C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
CPE |
carboxypeptidase E |
FXC09505
|
FHC09505
|
FNC09505N
|
FNC09505C
|
ELF2 |
E74-like factor 2 (ets domain transcription factor), transcript variant 2 |
FXC09540
|
FHC09540
|
FNC09540N
|
FNC09540C
|
GZMB |
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
FXC10250
|
FHC10250
|
FNC10250N
|
FNC10250C
|
LTA |
lymphotoxin alpha, transcript variant 2 |
FXC10320
|
FHC10320
|
FNC10320N
|
FNC10320C
|
CD86 |
CD86 molecule, transcript variant 1 |
FXC10363
|
FHC10363
|
FNC10363N
|
FNC10363C
|
GAD1 |
glutamate decarboxylase 1 (brain, 67kDa), transcript variant GAD67 |
FXC10493
|
FHC10493
|
FNC10493N
|
FNC10493C
|
HLA-DRB3 |
major histocompatibility complex, class II, DR beta 3
|
FXC10549
|
FHC10549
|
|
|
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1, transcript variant 1 |
FXC10550
|
FHC10550
|
FNC10550N
|
FNC10550C
|
IL12A |
interleukin 12A |
FXC10673
|
FHC10673
|
FNC10673N
|
FNC10673C
|
PRF1 |
perforin 1 (pore forming protein), transcript variant 1 |
FXC11041
|
FHC11041
|
FNC11041N
|
FNC11041C
|
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
FXC11450
|
FHC11450
|
FNC11450N
|
FNC11450C
|
SLC26A3 |
solute carrier family 26 (anion exchanger), member 3 |
FXC11726
|
FHC11726
|
FNC11726N
|
FNC11726C
|
PTPRN |
protein tyrosine phosphatase, receptor type, N, transcript variant 1 |
FXC12599
|
FHC12599
|
FNC12599N
|
FNC12599C
|
CD28 |
CD28 molecule, transcript variant 1 |
FXC21287
|
FHC21287
|
FNC21287N
|
FNC21287C
|
CD80 |
CD80 molecule |
FXC21656
|
FHC21656
|
FNC21656N
|
FNC21656C
|
IL12B |
interleukin 12B |
FXC22371
|
FHC22371
|
FNC22371N
|
FNC22371C
|
IFNG |
interferon, gamma |
FXC24802
|
FHC24802
|
FNC24802N
|
FNC24802C
|
RBM45 |
RNA binding motif protein 45 |
FXC28752
|
FHC28752
|
FNC28752N
|
FNC28752C
|
IL2 |
interleukin 2 |
FXC31382
|
FHC31382
|
FNC31382N
|
FNC31382C
|
KCNJ11 |
potassium channel, inwardly rectifying subfamily J, member 11, transcript variant 1 |
FXC00002
|
FHC00002
|
FNC00002N
|
FNC00002C
|
IRS1 |
insulin receptor substrate 1 |
FXC00972
|
FHC00972
|
FNC00972N
|
FNC00972C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
FXC01207
|
FHC01207
|
FNC01207N
|
FNC01207C
|
HK2 |
hexokinase 2 |
FXC01230
|
FHC01230
|
FNC01230N
|
FNC01230C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
MAPK1 |
mitogen-activated protein kinase 1, transcript variant 1 |
FXC01388
|
FHC01388
|
FNC01388N
|
FNC01388C
|
HK1 |
hexokinase 1, transcript variant 1 |
FXC01417
|
FHC01417
|
FNC01417N
|
FNC01417C
|
MAPK3 |
mitogen-activated protein kinase 3, transcript variant 1 |
FXC01500
|
FHC01500
|
FNC01500N
|
FNC01500C
|
PRKCE |
protein kinase C, epsilon |
FXC01866
|
FHC01866
|
FNC01866N
|
FNC01866C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
SOCS1 |
suppressor of cytokine signaling 1 |
FXC03002
|
FHC03002
|
FNC03002N
|
FNC03002C
|
SOCS3 |
suppressor of cytokine signaling 3 |
FXC03005
|
FHC03005
|
FNC03005N
|
FNC03005C
|
SOCS4 |
suppressor of cytokine signaling 4, transcript variant 2 |
FXC03049
|
FHC03049
|
FNC03049N
|
FNC03049C
|
SOCS6 |
suppressor of cytokine signaling 6 |
FXC03063
|
FHC03063
|
FNC03063N
|
FNC03063C
|
PDX1 |
pancreatic and duodenal homeobox 1 |
FXC03103
|
FHC03103
|
FNC03103N
|
FNC03103C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
KCNA5 |
potassium channel, voltage gated shaker related subfamily A, member 5 |
FXC03379
|
FHC03379
|
FNC03379N
|
FNC03379C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
PRKCD |
protein kinase C, delta, transcript variant 1 |
FXC03651
|
FHC03651
|
FNC03651N
|
FNC03651C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
HK3 |
hexokinase 3 (white cell) |
FXC03735
|
FHC03735
|
FNC03735N
|
FNC03735C
|
HOOK2 |
hook microtubule-tethering protein 2, transcript variant 2 |
FXC03747
|
FHC03747
|
FNC03747N
|
FNC03747C
|
SLC2A4 |
solute carrier family 2 (facilitated glucose transporter), member 4 |
FXC03812
|
FHC03812
|
FNC03812N
|
FNC03812C
|
SLC2A2 |
solute carrier family 2 (facilitated glucose transporter), member 2, transcript variant 1 |
FXC03947
|
FHC03947
|
FNC03947N
|
FNC03947C
|
KLK3 |
kallikrein-related peptidase 3, transcript variant 1 |
FXC05774
|
FHC05774
|
FNC05774N
|
FNC05774C
|
PRKCZ |
protein kinase C, zeta, transcript variant 1 |
FXC06489
|
FHC06489
|
FNC06489N
|
FNC06489C
|
SOCS2 |
suppressor of cytokine signaling 2, transcript variant 1 |
FXC07692
|
FHC07692
|
FNC07692N
|
FNC07692C
|
PKM |
pyruvate kinase, muscle, transcript variant 1 |
FXC07869
|
FHC07869
|
FNC07869N
|
FNC07869C
|
INS |
insulin, transcript variant 1 |
FXC08231
|
FHC08231
|
FNC08231N
|
FNC08231C
|
KIF2A |
kinesin heavy chain member 2A |
FXC09385
|
FHC09385
|
FNC09385N
|
FNC09385C
|
GCK |
glucokinase (hexokinase 4), transcript variant 1 |
FXC09784
|
FHC09784
|
FNC09784N
|
FNC09784C
|
KLK2 |
kallikrein-related peptidase 2, transcript variant 1 |
FXC09859
|
FHC09859
|
FNC09859N
|
FNC09859C
|
PKLR |
pyruvate kinase, liver and RBC, transcript variant 1 |
FXC10197
|
FHC10197
|
FNC10197N
|
FNC10197C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
INSR |
insulin receptor, transcript variant 2 |
FXC11132
|
FHC11132
|
FNC11132N
|
FNC11132C
|
MAP4K2 |
mitogen-activated protein kinase kinase kinase kinase 2 |
FXC12634
|
FHC12634
|
FNC12634N
|
FNC12634C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
CACNA1G |
calcium channel, voltage-dependent, T type, alpha 1G subunit, transcript variant 1 |
FXC15883
|
FHC15883
|
FNC15883N
|
FNC15883C
|
ADIPOQ |
adiponectin, C1Q and collagen domain containing, transcript variant 2 |
FXC21795
|
FHC21795
|
FNC21795N
|
FNC21795C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
IRS2 |
insulin receptor substrate 2 |
FXC25060
|
FHC25060
|
FNC25060N
|
FNC25060C
|
IRS4 |
insulin receptor substrate 4 |
FXC27470
|
FHC27470
|
FNC27470N
|
FNC27470C
|
KCNA4 |
potassium channel, voltage gated shaker related subfamily A, member 4 |
FXC29639
|
FHC29639
|
FNC29639N
|
FNC29639C
|
MAFA |
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A |
FXC31711
|
FHC31711
|
FNC31711N
|
FNC31711C
|
ABCC8 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 8, transcript variant 1
|
FXC31724
|
FHC31724
|
|
|
FASN |
fatty acid synthase |
FXC00314
|
FHC00314
|
FNC00314N
|
FNC00314C
|
IRS1 |
insulin receptor substrate 1 |
FXC00972
|
FHC00972
|
FNC00972N
|
FNC00972C
|
PIK3CA |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
FXC01204
|
FHC01204
|
FNC01204N
|
FNC01204C
|
MAPK9 |
mitogen-activated protein kinase 9, transcript variant JNK2-b2 |
FXC01315
|
FHC01315
|
FNC01315N
|
FNC01315C
|
PIK3CB |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta, transcript variant 1 |
FXC01319
|
FHC01319
|
FNC01319N
|
FNC01319C
|
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
FXC01323
|
FHC01323
|
FNC01323N
|
FNC01323C
|
PIK3R3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma), transcript variant 1 |
FXC01326
|
FHC01326
|
FNC01326N
|
FNC01326C
|
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
FXC01467
|
FHC01467
|
FNC01467N
|
FNC01467C
|
GSK3B |
glycogen synthase kinase 3 beta, transcript variant 2 |
FXC01477
|
FHC01477
|
FNC01477N
|
FNC01477C
|
BID |
BH3 interacting domain death agonist, transcript variant 1 |
FXC01493
|
FHC01493
|
FNC01493N
|
FNC01493C
|
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
FXC01530
|
FHC01530
|
FNC01530N
|
FNC01530C
|
JUN |
jun proto-oncogene |
FXC01532
|
FHC01532
|
FNC01532N
|
FNC01532C
|
PIK3R2 |
phosphoinositide-3-kinase, regulatory subunit 2 (beta), transcript variant 1 |
FXC01882
|
FHC01882
|
FNC01882N
|
FNC01882C
|
BCL2L11 |
BCL2-like 11 (apoptosis facilitator), transcript variant 6 |
FXC02123
|
FHC02123
|
FNC02123N
|
FNC02123C
|
PRKAG1 |
protein kinase, AMP-activated, gamma 1 non-catalytic subunit, transcript variant 1 |
FXC02192
|
FHC02192
|
FNC02192N
|
FNC02192C
|
AKT1 |
v-akt murine thymoma viral oncogene homolog 1, transcript variant 1 |
FXC02215
|
FHC02215
|
FNC02215N
|
FNC02215C
|
TNF |
tumor necrosis factor |
FXC02535
|
FHC02535
|
FNC02535N
|
FNC02535C
|
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1), transcript variant Rac1 |
FXC02699
|
FHC02699
|
FNC02699N
|
FNC02699C
|
AKT3 |
v-akt murine thymoma viral oncogene homolog 3 |
FXC02812
|
FHC02812
|
FNC02812N
|
FNC02812C
|
KCTD14 |
potassium channel tetramerization domain containing 14, transcript variant 2 |
FXC03004
|
FHC03004
|
FNC03004N
|
FNC03004C
|
SOCS3 |
suppressor of cytokine signaling 3 |
FXC03005
|
FHC03005
|
FNC03005N
|
FNC03005C
|
LEP |
leptin |
FXC03079
|
FHC03079
|
FNC03079N
|
FNC03079C
|
MAPK10 |
mitogen-activated protein kinase 10, transcript variant 3 |
FXC03139
|
FHC03139
|
FNC03139N
|
FNC03139C
|
PPARA |
peroxisome proliferator-activated receptor alpha, transcript variant 5 |
FXC03156
|
FHC03156
|
FNC03156N
|
FNC03156C
|
XBP1 |
X-box binding protein 1, transcript variant 1 |
FXC03159
|
FHC03159
|
FNC03159N
|
FNC03159C
|
RXRA |
retinoid X receptor, alpha, transcript variant 1 |
FXC03289
|
FHC03289
|
FNC03289N
|
FNC03289C
|
MAPK8 |
mitogen-activated protein kinase 8, transcript variant JNK1-b2 |
FXC03521
|
FHC03521
|
FNC03521N
|
FNC03521C
|
MLXIPL |
MLX interacting protein-like, transcript variant 1 |
FXC03526
|
FHC03526
|
FNC03526N
|
FNC03526C
|
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta, transcript variant 1 |
FXC03657
|
FHC03657
|
FNC03657N
|
FNC03657C
|
MLX |
MLX, MAX dimerization protein, transcript variant 1 |
FXC03683
|
FHC03683
|
FNC03683N
|
FNC03683C
|
IL6R |
interleukin 6 receptor, transcript variant 1 |
FXC03794
|
FHC03794
|
FNC03794N
|
FNC03794C
|
ATF4 |
activating transcription factor 4, transcript variant 1 |
FXC04200
|
FHC04200
|
FNC04200N
|
FNC04200C
|
COX5B |
cytochrome c oxidase subunit Vb |
FXC04615
|
FHC04615
|
FNC04615N
|
FNC04615C
|
FAS |
Fas cell surface death receptor |
FXC04988
|
FHC04988
|
FNC04988N
|
FNC04988C
|
IL1A |
interleukin 1, alpha |
FXC05509
|
FHC05509
|
FNC05509N
|
FNC05509C
|
IL1B |
interleukin 1, beta |
FXC05510
|
FHC05510
|
FNC05510N
|
FNC05510C
|
DDIT3 |
DNA-damage-inducible transcript 3, transcript variant 5 |
FXC06075
|
FHC06075
|
FNC06075N
|
FNC06075C
|
NDUFB1 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 1, 7kDa |
FXC06127
|
FHC06127
|
FNC06127N
|
FNC06127C
|
NDUFB9 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa, transcript variant 1 |
FXC06128
|
FHC06128
|
FNC06128N
|
FNC06128C
|
NR1H3 |
nuclear receptor subfamily 1, group H, member 3, transcript variant 1 |
FXC06191
|
FHC06191
|
FNC06191N
|
FNC06191C
|
RELA |
v-rel avian reticuloendotheliosis viral oncogene homolog A, transcript variant 1 |
FXC06624
|
FHC06624
|
FNC06624N
|
FNC06624C
|
TANK |
TRAF family member-associated NFKB activator, transcript variant 1 |
FXC07067
|
FHC07067
|
FNC07067N
|
FNC07067C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 2 |
FXC07774
|
FHC07774
|
FNC07774N
|
FNC07774C
|
CYCS |
cytochrome c, somatic |
FXC07778
|
FHC07778
|
FNC07778N
|
FNC07778C
|
COX6C |
cytochrome c oxidase subunit VIc |
FXC07836
|
FHC07836
|
FNC07836N
|
FNC07836C
|
UQCRC2 |
ubiquinol-cytochrome c reductase core protein II |
FXC07872
|
FHC07872
|
FNC07872N
|
FNC07872C
|
UQCRFS1 |
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 |
FXC07903
|
FHC07903
|
FNC07903N
|
FNC07903C
|
NDUFV2 |
NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa |
FXC08018
|
FHC08018
|
FNC08018N
|
FNC08018C
|
EIF2S1 |
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
FXC08071
|
FHC08071
|
FNC08071N
|
FNC08071C
|
NDUFA10 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa |
FXC08150
|
FHC08150
|
FNC08150N
|
FNC08150C
|
INS |
insulin, transcript variant 1 |
FXC08231
|
FHC08231
|
FNC08231N
|
FNC08231C
|
SDHD |
succinate dehydrogenase complex, subunit D, integral membrane protein, transcript variant 1 |
FXC08233
|
FHC08233
|
FNC08233N
|
FNC08233C
|
COX6A1 |
cytochrome c oxidase subunit VIa polypeptide 1 |
FXC08343
|
FHC08343
|
FNC08343N
|
FNC08343C
|
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
FXC08484
|
FHC08484
|
FNC08484N
|
FNC08484C
|
CXCL8 |
chemokine (C-X-C motif) ligand 8 |
FXC08702
|
FHC08702
|
FNC08702N
|
FNC08702C
|
IL6 |
interleukin 6 |
FXC08788
|
FHC08788
|
FNC08788N
|
FNC08788C
|
NDUFV1 |
NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa, transcript variant 1 |
FXC08801
|
FHC08801
|
FNC08801N
|
FNC08801C
|
CASP3 |
caspase 3, apoptosis-related cysteine peptidase, transcript variant alpha |
FXC08865
|
FHC08865
|
FNC08865N
|
FNC08865C
|
FASLG |
Fas ligand (TNF superfamily, member 6), transcript variant 1 |
FXC08901
|
FHC08901
|
FNC08901N
|
FNC08901C
|
NDUFB3 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa, transcript variant 1 |
FXC08953
|
FHC08953
|
FNC08953N
|
FNC08953C
|
COX7B |
cytochrome c oxidase subunit VIIb |
FXC08960
|
FHC08960
|
FNC08960N
|
FNC08960C
|
CYC1 |
cytochrome c-1 |
FXC09013
|
FHC09013
|
FNC09013N
|
FNC09013C
|
COX5A |
cytochrome c oxidase subunit Va |
FXC09137
|
FHC09137
|
FNC09137N
|
FNC09137C
|
GSK3A |
glycogen synthase kinase 3 alpha |
FXC09232
|
FHC09232
|
FNC09232N
|
FNC09232C
|
COX6A2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
FXC09312
|
FHC09312
|
FNC09312N
|
FNC09312C
|
TRAF2 |
TNF receptor-associated factor 2 |
FXC09417
|
FHC09417
|
FNC09417N
|
FNC09417C
|
NDUFA6 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6, 14kDa |
FXC09677
|
FHC09677
|
FNC09677N
|
FNC09677C
|
NDUFS2 |
NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC09693
|
FHC09693
|
FNC09693N
|
FNC09693C
|
NDUFS3 |
NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase) |
FXC09729
|
FHC09729
|
FNC09729N
|
FNC09729C
|
COX6B1 |
cytochrome c oxidase subunit VIb polypeptide 1 (ubiquitous) |
FXC09747
|
FHC09747
|
FNC09747N
|
FNC09747C
|
COX7A2L |
cytochrome c oxidase subunit VIIa polypeptide 2 like |
FXC09862
|
FHC09862
|
FNC09862N
|
FNC09862C
|
CASP7 |
caspase 7, apoptosis-related cysteine peptidase, transcript variant a |
FXC10056
|
FHC10056
|
FNC10056N
|
FNC10056C
|
PKLR |
pyruvate kinase, liver and RBC, transcript variant 1 |
FXC10197
|
FHC10197
|
FNC10197N
|
FNC10197C
|
PTGS1 |
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase), transcript variant 1 |
FXC10242
|
FHC10242
|
FNC10242N
|
FNC10242C
|
NDUFA13 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 |
FXC10634
|
FHC10634
|
FNC10634N
|
FNC10634C
|
BAX |
BCL2-associated X protein, transcript variant beta |
FXC10662
|
FHC10662
|
FNC10662N
|
FNC10662C
|
CLSTN1 |
calsyntenin 1, transcript variant 1 |
FXC10700
|
FHC10700
|
FNC10700N
|
FNC10700C
|
NDUFC2 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa, transcript variant 1 |
FXC10813
|
FHC10813
|
FNC10813N
|
FNC10813C
|
CEBPA |
CCAAT/enhancer binding protein (C/EBP), alpha, transcript variant 1 |
FXC10825
|
FHC10825
|
FNC10825N
|
FNC10825C
|
ITCH |
itchy E3 ubiquitin protein ligase, transcript variant 2 |
FXC11019
|
FHC11019
|
FNC11019N
|
FNC11019C
|
INSR |
insulin receptor, transcript variant 2 |
FXC11132
|
FHC11132
|
FNC11132N
|
FNC11132C
|
CDC42 |
cell division cycle 42, transcript variant 2 |
FXC11496
|
FHC11496
|
FNC11496N
|
FNC11496C
|
SDHA |
succinate dehydrogenase complex, subunit A, flavoprotein (Fp), transcript variant 1 |
FXC11617
|
FHC11617
|
FNC11617N
|
FNC11617C
|
COX7C |
cytochrome c oxidase subunit VIIc |
FXC11906
|
FHC11906
|
FNC11906N
|
FNC11906C
|
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, transcript variant 1 |
FXC11986
|
FHC11986
|
FNC11986N
|
FNC11986C
|
SREBF1 |
sterol regulatory element binding transcription factor 1, transcript variant 1 |
FXC12086
|
FHC12086
|
FNC12086N
|
FNC12086C
|
CASP8 |
caspase 8, apoptosis-related cysteine peptidase, transcript variant G |
FXC12541
|
FHC12541
|
FNC12541N
|
FNC12541C
|
PIK3CD |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
FXC12640
|
FHC12640
|
FNC12640N
|
FNC12640C
|
COX4I1 |
cytochrome c oxidase subunit IV isoform 1 |
FXC13106
|
FHC13106
|
FNC13106N
|
FNC13106C
|
COX7A2 |
cytochrome c oxidase subunit VIIa polypeptide 2 (liver) |
FXC13423
|
FHC13423
|
FNC13423N
|
FNC13423C
|
NDUFV3 |
NADH dehydrogenase (ubiquinone) flavoprotein 3, 10kDa, transcript variant 2 |
FXC14706
|
FHC14706
|
FNC14706N
|
FNC14706C
|
PPARA |
peroxisome proliferator-activated receptor alpha
|
FXC15234
|
FHC15234
|
|
|
PRKAG3 |
protein kinase, AMP-activated, gamma 3 non-catalytic subunit |
FXC16543
|
FHC16543
|
FNC16543N
|
FNC16543C
|
NDUFS5 |
NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC20237
|
FHC20237
|
FNC20237N
|
FNC20237C
|
PRKAA2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
FXC20333
|
FHC20333
|
FNC20333N
|
FNC20333C
|
LEPR |
leptin receptor, transcript variant 1
|
FXC20344
|
FHC20344
|
|
|
PRKAB2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit, transcript variant 1 |
FXC20516
|
FHC20516
|
FNC20516N
|
FNC20516C
|
SDHC |
succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa, transcript variant 1 |
FXC20677
|
FHC20677
|
FNC20677N
|
FNC20677C
|
ADIPOR1 |
adiponectin receptor 1, transcript variant 1 |
FXC20774
|
FHC20774
|
FNC20774N
|
FNC20774C
|
NDUFS1 |
NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase), transcript variant 1 |
FXC21290
|
FHC21290
|
FNC21290N
|
FNC21290C
|
UQCRC1 |
ubiquinol-cytochrome c reductase core protein I |
FXC21528
|
FHC21528
|
FNC21528N
|
FNC21528C
|
ADIPOQ |
adiponectin, C1Q and collagen domain containing, transcript variant 2 |
FXC21795
|
FHC21795
|
FNC21795N
|
FNC21795C
|
COX7B2 |
cytochrome c oxidase subunit VIIb2 |
FXC21906
|
FHC21906
|
FNC21906N
|
FNC21906C
|
NDUFS6 |
NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) |
FXC22122
|
FHC22122
|
FNC22122N
|
FNC22122C
|
PRKAA1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit, transcript variant 1 |
FXC22157
|
FHC22157
|
FNC22157N
|
FNC22157C
|
NDUFS4 |
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) |
FXC22169
|
FHC22169
|
FNC22169N
|
FNC22169C
|
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha), transcript variant 2 |
FXC22191
|
FHC22191
|
FNC22191N
|
FNC22191C
|
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma, transcript variant 1 |
FXC23046
|
FHC23046
|
|
|
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit, transcript variant b |
FXC23158
|
FHC23158
|
FNC23158N
|
FNC23158C
|
UQCRB |
ubiquinol-cytochrome c reductase binding protein, transcript variant 1 |
FXC23350
|
FHC23350
|
FNC23350N
|
FNC23350C
|
NDUFB6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa, transcript variant 1 |
FXC23492
|
FHC23492
|
FNC23492N
|
FNC23492C
|
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
FXC24085
|
FHC24085
|
FNC24085N
|
FNC24085C
|
COX8A |
cytochrome c oxidase subunit VIIIA (ubiquitous) |
FXC24280
|
FHC24280
|
FNC24280N
|
FNC24280C
|
MAP3K11 |
mitogen-activated protein kinase kinase kinase 11 |
FXC24308
|
FHC24308
|
FNC24308N
|
FNC24308C
|
NDUFA12 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12, transcript variant 1 |
FXC24832
|
FHC24832
|
FNC24832N
|
FNC24832C
|
PRKAB1 |
protein kinase, AMP-activated, beta 1 non-catalytic subunit |
FXC24903
|
FHC24903
|
FNC24903N
|
FNC24903C
|
IRS2 |
insulin receptor substrate 2 |
FXC25060
|
FHC25060
|
FNC25060N
|
FNC25060C
|
RNASE1 |
ribonuclease, RNase A family, 1 (pancreatic), transcript variant 4 |
FXC25083
|
FHC25083
|
FNC25083N
|
FNC25083C
|
COX8C |
cytochrome c oxidase subunit VIIIC |
FXC25279
|
FHC25279
|
FNC25279N
|
FNC25279C
|
AKT2 |
v-akt murine thymoma viral oncogene homolog 2, transcript variant 1 |
FXC26633
|
FHC26633
|
FNC26633N
|
FNC26633C
|
NDUFA1 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa |
FXC27495
|
FHC27495
|
FNC27495N
|
FNC27495C
|
UQCRH |
ubiquinol-cytochrome c reductase hinge protein, transcript variant 1 |
FXC27655
|
FHC27655
|
FNC27655N
|
FNC27655C
|
TGFB1 |
transforming growth factor, beta 1 |
FXC28628
|
FHC28628
|
FNC28628N
|
FNC28628C
|
UQCRQ |
ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa |
FXC29084
|
FHC29084
|
FNC29084N
|
FNC29084C
|
UQCR10 |
ubiquinol-cytochrome c reductase, complex III subunit X, transcript variant 1 |
FXC30961
|
FHC30961
|
FNC30961N
|
FNC30961C
|